The revelation by the FDA earlier this month that Novartis not only relied on manipulated data in a drug’s application, but did so knowingly, has put pressure on its CEO Vas Narasimhan.
Source: Business News –
By musthavesla
The revelation by the FDA earlier this month that Novartis not only relied on manipulated data in a drug’s application, but did so knowingly, has put pressure on its CEO Vas Narasimhan.
Source: Business News –
MustHaves.LA a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for us to earn fees by linking to Amazon.com and affiliated sites.